Status:
WITHDRAWN
Gabapentin and Chronic Post Surgical Pain
Lead Sponsor:
Emory University
Conditions:
Pain, Postoperative
Scoliosis Idiopathic
Eligibility:
All Genders
10-18 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to investigate the effect of a common pain medication (gabapentin) on chronic postsurgical pain in pediatric patients who require surgery for idiopathic scoliosis.
Detailed Description
Pain after surgery can last for a long time. When it lasts for over two months, it is considered chronic postsurgical pain (CPSP). This is a problem in kids and adolescents that can impact many areas ...
Eligibility Criteria
Inclusion
- Be aged 10-18 years at the time of surgery
- Have a diagnosis of idiopathic scoliosis and/or kyphosis
- Be undergoing elective posterior spinal fusion
- Have only mild systemic disease
Exclusion
- A diagnosis of neuromuscular scoliosis and/or kyphosis
- A diagnosis of chronic pain
- Used opioids in the past 6 months
- Developmental delay
- Liver or kidney disease
- Obstructive sleep apnea
- Body mass index \>40
- Be pregnant or breastfeeding
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03867240
Start Date
June 1 2019
End Date
September 1 2022
Last Update
February 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30322